Pulsed Field Ablation for Atrial Fibrillation (PARALELL Trial)

"According to the stipulations of this clinical trial, patients have to be aged between 18 and 80. Those beneath 18 can register for 11 separate trials while those over 65 may participate in 478 different studies."

"Affirmative, the information on clinicaltrials.gov suggests that this experiment is actively recruiting candidates. This research was initially posted online on October 20th 2022 and has been adjusted most recently on December 13th 2022. Altogether 78 participants are needed at a single site for its successful completion."

"Affirmative. According to clinicaltrials.gov, this research is still recruiting participants having initially been posted on October 20th 2022 and most recently updated on December 13th 2022. 78 individuals are required from one location."

"According to the trial sponsor, Adagio Medical, the primary outcome measured in this study is 'Primary Procedural Performance Outcome' over a period of 7 days. In addition to this metric, secondary outcomes such as 'One-Year Performance', 'Procedure Time', and 'Intraprocedural PV Reconnection Rate' are also being monitored."

"This clinical trial is searching for 78 individuals, aged between 18 and 80 years old, who have been diagnosed with atrial fibrillation. To be eligible for this study, volunteers must meet the following criteria: (1) Male or female of legal age; (2) Resistant to Class I or III AADs; (3) Willingness and capacity to provide informed consent; (4) Commitment to complete all baseline evaluations over the course of the research project; and (5) Having undergone a recent ablation of persistent (> 7 days), symptomatic AF as revealed by ECG recordings or Holter monitoring."